Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Ding

Showing results (711-720 of 716) with videos related to

Pageof 72
Sort By:
You have reached the last page of results.This site can display upto 716 results.
Nature|April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cell Reports. Medicine|October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Nature Cancer|November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.
Nature Genetics|September 9, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Cytoskeleton (Hoboken, N.J.)|June 3, 2017
Flow-aligned, single-shot fiber diffraction using a femtosecond X-ray free-electron laserDavid Popp, N Duane Loh, Habiba Zorgati, et al.
Pageof 72

Showing results (711-720 of 716) with videos related to

Sort By:
Pageof 72
You have reached the last page of results.This site can display upto 716 results.
Nature|April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancerCaleb Cheng, Jing Hu, Rahul Mannan, et al.
Biorxiv : the Preprint Server for Biology|April 2, 2024
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic LethalityJean Ching-Yi Tien, Yu Chang, Yuping Zhang, et al.
Cell Reports. Medicine|October 5, 2024
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13Jean Ching-Yi Tien, Jie Luo, Yu Chang, et al.
Nature Cancer|November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.
Nature Genetics|September 9, 2024
NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesisAbhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma, et al.
Cytoskeleton (Hoboken, N.J.)|June 3, 2017
Flow-aligned, single-shot fiber diffraction using a femtosecond X-ray free-electron laserDavid Popp, N Duane Loh, Habiba Zorgati, et al.
Pageof 72